Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism.
- 1 November 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 10 (6) , 1088-1096
- https://doi.org/10.1161/01.atv.10.6.1088
Abstract
The metabolism of very low density lipoprotein (VLDL) from normolipemic (NTG) subjects, hypertriglyceridemic (HTG) subjects, and hypertriglyceridemic subjects treated with bezafibrate (BZ) was studied in cultured human skin fibroblasts. The binding, cell association, and proteolytic degradation of 125I-labeled lipoproteins and the capacity to regulate cellular sterol synthesis was determined with and without maximal stimulation of the lipoprotein by exogenous recombinant or plasmatic apolipoprotein (apo) E-3. The VLDL was separated into three density subfractions: I, II, and III. Multiple differences between HTG and NTG lipoproteins were found, which all reverted toward normal with therapy. Even in the presence of an optimal concentration of apo E-3, HTG-VLDL demonstrated 100% to 200% higher metabolic activities, indicating a better association or a better biological expression of apo E-3 at the surface of the lipoprotein. There was a strong and linear relationship between the cholesterol ester/protein ratios of the different VLDLs and their proteolytic degradations by the cells (r = 0.95). Thus, the composition/structure alterations of VLDL appear to determine their apo E-3-dependent cellular catabolism. In addition, HTG-VLDLs not enriched with apo E-3 exhibited a capacity to down-regulate cellular sterol synthesis independently of their uptake and degradation by the cells. This abnormality appeared to reflect the ability of the VLDL to donate cholesterol to the cells and was not observed in receptor-negative cells. Thus, HTG-VLDL is much more capable than NTG-VLDL of introducing cholesterol to cells by at least two mechanisms: 1) accelerated uptake and degradation and 2) direct transfer of cholesterol to the cells. Both processes are potentially atherogenic and are reversible when triglyceride-lowering therapy is instituted.This publication has 40 references indexed in Scilit:
- Cellular metabolism of human plasma intermediate-density lipoprotein (IDL)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: A saturable pathway distinct from the LDL receptorBiochemical and Biophysical Research Communications, 1985
- Lipoprotein lipase mediated uptake of non-degradable ether analogues of phosphatidylcholine and cholesteryl ester by cultured cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- The role of lipoprotein lipase in the assimilation of cholesteryl linoleyl ether by cultured cells incubated with labeled chylomicronsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Radioimmunoassay studies of human apolipoprotein E.Journal of Clinical Investigation, 1980
- Control of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Activity in Cultured Human Fibroblasts by Very Low Density Lipoproteins of Subjects with HypertriglyceridemiaJournal of Clinical Investigation, 1978
- Deposition and mobilization of cholesterol ester in cultured human skin fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Metabolism of rat plasma very low density lipoprotein: II. fate in circulation of apoprotein subunitsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972